Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer-Reference-Cited by-同舟云学术

Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer

Published:2018-11-15 Issue:12 Volume:16 Page:2492-2500
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Van Matre E. T.¹^ORCID,Reynolds P. M.²,MacLaren R.²,Mueller S. W.²,Wright G. C.²,Moss M.³,Burnham E. L.³,Ho P. M.⁴⁵,Vandivier R. W.³,Kiser T. H.²^ORCID

Affiliation:

1. Department of Clinical Pharmacy and Translational Science; University of Tennessee Health Science Center College of Pharmacy; Memphis TN USA

2. Department of Clinical Pharmacy; University of Colorado; Skaggs School of Pharmacy and Pharmaceutical Sciences; Anschutz Medical Campus; Aurora CO USA

3. Division of Pulmonary Sciences and Critical Care Medicine; Department of Medicine; University of Colorado Denver; Anschutz Medical Campus; Aurora CO USA

4. Colorado Pulmonary Outcomes Research Group (CPOR); University of Colorado; Anschutz Medical Campus; Aurora

5. Division of Cardiology; Department of Medicine; VA Eastern Colorado Health Care System; Denver CO USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.14317/fullpdf

Reference22 articles.

1. Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors;Cook;Crit Care Med,2005

2. Venous thromboembolism and its prevention in critical care;Geerts;J Crit Care,2002

3. Incidence of venous thromboembolism and its effect on survival among patients with common cancers;Chew;Arch Intern Med,2006